Claims for Patent: 11,045,523
✉ Email this page to a colleague
Summary for Patent: 11,045,523
| Title: | Formulation of growth hormone albumin-binder conjugate |
| Abstract: | The present invention relates to compositions of growth hormone albumin-binder conjugates including pharmaceutical formulations. The compositions are able to provide initial and long term stability of the growth hormone albumin-binder conjugate, rendering such compositions suited for use as a pharmaceutical formulation. |
| Inventor(s): | Nielsen Jette, Eskling Marie, Christensen Stina Granzau |
| Assignee: | NOVO NORDISK HEALTHCARE AG |
| Application Number: | US14780161 |
| Patent Claims: |
Details for Patent 11,045,523
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Novo Nordisk Inc. | SOGROYA | somapacitan-beco | Injection | 761156 | August 28, 2020 | 11,045,523 | 2034-04-04 |
| Novo Nordisk Inc. | SOGROYA | somapacitan-beco | Injection | 761156 | October 01, 2021 | 11,045,523 | 2034-04-04 |
| Novo Nordisk Inc. | SOGROYA | somapacitan-beco | Injection | 761156 | April 28, 2023 | 11,045,523 | 2034-04-04 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 11,045,523
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2014166836 | ⤷ Start Trial |
| United States of America | 2016058879 | ⤷ Start Trial |
| Japan | 6464145 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
